Davis Polk & Wardwell represented Roivant Sciences, while Latham & Watkins represented the underwriters in the offering.Roivant Sciences (Nasdaq: ROIV) has announced its $230 million SEC-registered…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
